2 recruiting, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Completed 1 |
Follow Semaglutide Injectable Product: new trials by email Literature Review of Semaglutide Injectable Product trials Research Report on Semaglutide Injectable Product
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity Semaglutide Injectable Product, Placebo - Major Depressive Disorder | Phase 4 | Recruiting | Nordsjaellands Hospital | 116 | 2025-09-11 | 2026-02-06 |
| Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes Semaglutide Injectable Product, Placebo - Spinal Cord Injuries, Type 2 Diabetes | Phase 4 | Recruiting | Marzieh Salehi | 50 | 2025-04-11 | 2026-10-05 |
| Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults Semaglutide Injectable Product, Lifestyle Counseling - Aging, Diabetes Mellitus, Type 2 | Phase 4 | Completed | The University of Texas Health Science Center at San Antonio | 20 | 2023-04-01 | 2025-05-04 |
Diabetes Mellitus, Type 2 (2) · Depression (1) · Depressive Disorder, Major (1) · Obesity (1) · Overweight (1) · Prediabetic State (1) · Spinal Cord Injuries (1)
Marzieh Salehi (1) · Nordsjaellands Hospital (1) · The University of Texas Health Science Center at San Antonio (1)
United States (2) · Denmark (1)
Maj Vinberg, MD, PhD, DMSc (1) · Marzieh Salehi, MD (1) · Tiffany M Cortes, MD (1)
P30AG044271 (1), R01DK140144 (1)